CD4 and neoplasm: The anti-PD-1 antibody showed an inhibitory effect on Treg generation when the CD4+ T cells were cultured with the IL-21high/PD-L1high tumor explants (31.3 ± 5.0% vs. 38.8 ± 8.5%, P < 0.05).